DOW Jones Declines Despite Broad Market Rally, Healthcare Stocks Plummet After Trump’s Prescription Drug Price Order

Despite a broad market rally driven by the easing of US-China trade tensions, the DOW Jones declined 178 points on Tuesday, impacted largely by declining profit expectations from major U.S. healthcare firms. This trend contrasts with the positive momentum witnessed in the S&P 500 (up 0.85%) and Nasdaq (up 1.7%), as tech stocks like Nvidia, Amazon, and IBM flourished.